Parmax Pharma Limited announced unaudited standalone earnings results for the first quarter ended 30 June, 2019. For the quarter, the company reported revenue from operations of INR 41,134,972 against INR 33,827,442 a year ago. Total income from operations was INR 41,322,238 against INR 33,870,036 a year ago. Net loss for the period was INR 2,854,628 against the profit of INR 614,136 a year ago. Basic loss per share was INR 0.76 against income per share of INR 0.16 a year ago.